We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Device Detects Malaria in Simple Blood Test

By LabMedica International staff writers
Posted on 18 May 2011
A diagnostic screening device, which separates malaria-infected red blood cells from uninfected red blood cells by way of magnetic levitation has been developed. More...


The prototype system requires less than a drop of finger-prick blood and a small volume of erythrocyte isotonic buffer containing paramagnetic ions and is lightweight, disposable, and inexpensive to manufacture.

Scientists at the Beth Israel Deaconess Medical Center (BIDMC; Boston, MA, USA) used the principles of magnetic levitation and cell phone technology to create an inexpensive, portable device to diagnose malaria quickly and accurately outside of the routine laboratory setting. The device uses a set of permanent magnets immobilized in a plastic structure surrounding a glass or plastic capillary containing the blood. Results are visualized, recorded and stored using a standard camera phone and no additional imaging equipment or staining reagents are required.

Ionita Ghiran, MD, an investigator at BIDMC and an assistant professor of medicine at Harvard Medical School (Boston, MA, USA) has been awarded a $100,000 grant from the Bill & Melinda Gates Foundation (Seattle WA, USA), for the development of the device. Professor Ghiran said, "The lack of suitable methods of malaria diagnosis makes presumptive treatment often the only available option for local health service providers. This method helps fill the need for malarial diagnostic technologies capable of promptly and reliably ascertaining true malarial infections in the field. We hope that this will help prevent the over diagnosis of malaria and subsequent drug resistance."

An estimated 200 to 500 million cases of malaria occur each year with 50% to 90% of these in Africa. Malaria causes nearly one million deaths per year throughout developing countries, 85% of whom are children under the age of five, and parasites are becoming increasingly resistant to antimalarial drugs, in part due to misdiagnosis.

Related Links:
Beth Israel Deaconess Medical Center
Harvard Medical School
Bill & Melinda Gates Foundation




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.